Listen "Disease-Modifying Therapy, Quantitative Imaging, and AI for Managing Patients with Alzheimer Disease"
Episode Synopsis
In this discussion, Dr Tanenbaum and Suzie Bash, MD, a Medical Director at RadNet in Los Angeles, cover the intersection of disease-modifying therapies (DMTs), quantitative imaging, and artificial intelligence (AI) in managing Alzheimer disease.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.